(Q61767312)
Statements
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune) (English)
Jeffrey Pido-Lopez
Catherine Burton
Gareth Hardy
Antonio Pires
Ann Sullivan
Brian Gazzard